At the heart of the MygoGenesis mission is the creation of personalized medical solutions that can be tailored to the individual genetic and cellular makeup of each patient. This is not just about creating new therapies; it’s about redefining healthcare. The MygoGenesis Team of expert scientists and researchers employ cutting-edge technology to create autologous totipotent cells from somatic cells (any cell in the body), aiming to develop novel treatments for a range of currently incurable diseases. From cardiac muscle regeneration, neural tissue repair, pancreatic cells for Type 1 diabetes, to vaccines for cancer, the possibilities are unlimited to transform medicine.

Beyond human medicine, MygoGenesis recognizes the critical need for advancements in public health, particularly in food, product and water safety. Our subsidiary, AmeboGenesis™  has developed sustainable, efficient, and unlimited production methods for laboratory produced amebocytes. These amebocytes contain LAL, which is  necessary  to detect potential lethal contaminants. This ensures unprecedented levels of purity and safety of all injectable drugs and implantable devices. This multifaceted approach not only promises to enhance quality of life, but also equips humanity with the tools to address and prevent crises stemming from contaminated resources.

MygoGenesis envisions a future where organ donors are not necessary for transplants but replaced by tissues grown from one’s own genetic blueprint. This eradicates the risk of rejection and the need for any immunosuppression. Utilizing our Mygotic Process™ another subsidiary, HematoGenesis™, would allow the unlimited laboratory production of Type O Negative blood, representing a major advancement in medical science and healthcare delivery. It would eliminate blood shortages and have profound implications for healthcare, emergency medicine, and military operations.

The work of MygoGenesis goes beyond the laboratory; it is a movement towards a future where the aging process is not a decline but a second stage for human potential, societal contributions, and physical vitality. MyCellSafe™ is advancing Personalized Medicine through a cell bank where autologous totipotent cells – cells derived from one’s own body – can be stored and available for future medical needs. Now every individual can “be their best donor” and access the genetic keys to their own health, happiness, and longevity.

As a beacon of thought leadership, MygoGenesis will collaborate with global healthcare organizations, policy makers, and the wider scientific community to share insights and shape the future of health, product, and environmental safety. Through our groundbreaking research and unwavering commitment to innovation, MygoGenesis stands at the forefront of a new era in science and medicine. Learn more about our Science and broad range of Market Opportunities.